Audent Global Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,064
Closed -$265K 67
2023
Q2
$265K Hold
2,064
0.22% 49
2023
Q1
$240K Hold
2,064
0.34% 40
2022
Q4
$234K Buy
+2,064
New +$227K 0.4% 37
2022
Q2
Sell
-1,740
Closed -$223K 49
2022
Q1
$223K Buy
+1,740
New +$190K 0.12% 47

Other funds holding DXCM

Audent Global Asset Management's DXCM Position: Q3 2023 in Review

Audent Global Asset Management sold out of DexCom (DXCM) in Q3 2023, closing a stake of 2,064 shares — an estimated $265K sold.

Audent Global Asset Management first reported a position in DXCM in Q1 2022 and held it in 4 quarters. The position peaked at $265K in Q2 2023. 903 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

  • Audent Global Asset Management reported no remaining DexCom position as of Q3 2023 after selling out during the quarter.
  • Audent Global Asset Management sold 2,064 DexCom shares in Q3 2023, an estimated $265K.
  • Audent Global Asset Management first reported a position in DexCom in Q1 2022 and held it in 4 quarters.
  • Audent Global Asset Management's DexCom position peaked at $265K in Q2 2023.
  • 903 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on Audent Global Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.